Acasti Pharma (CVE:ACST) Trading 1.8% Higher – Here’s Why

Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price shot up 1.8% during mid-day trading on Tuesday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares were traded during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Stock Up 1.8%

The company has a market capitalization of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22. The business has a 50 day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58.

About Acasti Pharma

(Get Free Report)

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Featured Stories

• Five stocks we like better than Acasti Pharma
• Microsoft Just Flipped the AI Spending Narrative Overnight
• Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
• Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
• Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes